Evaluation

Risks and Harms Associated with the Nonmedical Use of Benzodiazepines in the Unregulated Drug Supply in Canada

Report

25 December 2021

Summary Substance use risks are significantly higher for people who obtain drugs on the unregulated market as there is no quality control and drug contents are unpredictable. This lack of predictability has increased during the COVID-19...

New Trends in Education and Training Programs in Addictions at the Higher Education and University Levels

Scientific article

13 December 2021

BACKGROUND A broad range of professionals, training opportunities, and regional differences exist in the addiction study field worldwide. This educational variety poses a challenge in proposing a precise classification of study programs at...

The Master’s in Drug Dependence at the University of Barcelona: Historical Perspective and Future Challenges

Scientific article

5 August 2021

BACKGROUND The two-year, multidisciplinary Master’s in Drug Dependence (MDD) at the University of Barcelona was created in 1986, after some years of offering shorter seminars. It was a response to the heroin crisis of the 80s and 90s and...

Comprehensive Evaluation of the Online Lifelong Education Course Prevention and Treatment of Substance Use Disorders for Physicians in the Czech Republic: Study Protocol

Scientific article

18 September 2021

BACKGROUND The course Prevention of Harmful Substance Use and Addiction Treatment is an integral and mandatory part of postgraduate medical education in the Czech Republic. Its aim is to acquire the necessary knowledge, skills and...

Perspectives of healthcare providers, service users, and family members about mental illness stigma in primary care settings: A multi-site qualitative study of seven countries in Africa, Asia, and Europe

Scientific article

27 October 2021

Stigma among healthcare providers is a barrier to the effective delivery of mental health services in primary care. Few studies have been conducted in primary care settings comparing the attitudes of healthcare providers and experiences of...

Impact of Cannabis Legalization on Youth Contact with the Criminal Justice System

Book

4 November 2021

The Canadian Centre on Substance Use and Addiction (CCSA) provided funding to Dr. Akwasi Owusu-Bempah and Dr. Scot Wortley from the University of Toronto to research youth interactions with the criminal justice system, including the nature...

Considerations for Virtual Services and Supports for Substance Use and Concurrent Disorders [Policy Brief]

Book

28 October 2021

The Canadian Centre for Substance Use and Addiction (CCSA) in partnership with the Royal Ottawa Mental Health Centre, the Canadian Psychological Association and Canada Health Infoway, collected national data on the experience and...

Impact of the COVID-19 Pandemic on Behaviour and Preference Changes in Relation to Selected Anabolic Androgenic Substances and Steroids: A Research Study

Scientific article

14 July 2021

BACKGROUND: In December 2019, a severe acute respiratory syndrome caused by coronavirus 2 (SARS- CoV-2 or COVID-19) broke out in China. The virus spread rapidly throughout the country and around the globe. In an effort to prevent the spread...

Biographic Burden and Initiation into the Use of Amphetamine-Type Stimulants from the Perspective of Users: The Qualitative Arm of the ATTUNE Research Study in the Czech Republic

Scientific article

3 February 2021

BACKGROUND: The Czech Republic has a long tradition of methamphetamine use. Less is known about the circumstances of initiation into its use at the level of individual users. The aim of the research was to analyse the biographic burden...

Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017

Scientific article

20 October 2021

One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were...